Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker CustomersBusiness Wire • 01/04/23
Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 12/21/22
Bruker Energy & Supercon Technologies (BEST) Announces Multi-Year Orders for Key Magnetic Confinement Fusion TechnologiesBusiness Wire • 12/16/22
Functional precision oncology leader Kiyatec announces Series C round with US$18 million closing to accelerate adoption of transformational cancer platformBusiness Wire • 12/12/22
Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research PortfolioBusiness Wire • 11/14/22
Bruker Corporation to Participate in the 2022 Jefferies London Healthcare ConferenceBusiness Wire • 11/07/22
Bruker Announces Date and Time of Third Quarter 2022 Earnings Release and WebcastBusiness Wire • 10/21/22
Bruker Launches New nanoElute® 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape® 2023 SoftwareBusiness Wire • 08/29/22
Bruker Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR InnovationsBusiness Wire • 08/22/22
Bruker Corporation (BRKR) CEO Frank Laukien on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/04/22
Bruker Announces Date and Time of Second Quarter 2022 Earnings Release and WebcastBusiness Wire • 07/25/22
Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective Early-Cancer DetectionPRNewsWire • 07/20/22
Bruker Announces Three New GHz NMR Systems Orders for Functional Structural Biology and Clinical Phenomics ResearchBusiness Wire • 07/11/22